Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages

Pozo D, Delgado M, Martínez C, Gomariz RP, Guerrero JM, Calvo JR.

Biochim Biophys Acta. 1997 Dec 12;1359(3):250-62.

Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen

Pozo D, Delgado M, Fernandez-Santos JM, Calvo JR, Gomariz RP, Martin-Lacave I, Ortiz GG, Guerrero JM.

FASEB J. 1997 May;11(6):466-73. PDF

Ontogenic development of the adenylyl cyclase enzyme and the alpha s, alpha i1 and alpha i2 G-protein regulatory subunits from rat prostate

Juarranz MG, Carrero I, Busto R, Carmena MJ, Prieto JC, Guijarro LG.

Cell Signal. 1997 Sep;9(6):451-6.

Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus

Rodríguez-Sánchez MN, Puebla L, López-Sañudo S, Rodríguez-Martín E, Martín-Espinosa A, Rodríguez-Pena MS, Juarranz MG, Arilla E.

J Neurosci Res. 1997 May 1;48(3):238-48.

Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP, and carbachol: role in prostatic proliferation

Guijarro LG, Juarranz MG, Marinero MJ, Pajuelo L, Carmena MJ, Prieto JC.

Ann N Y Acad Sci. 1996 Dec 26;805:723-8.

Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility

Garrido E, Delgado M, Martínez C, Gomariz RP, De la Fuente M.

Neuropeptides. 1996 Dec;30(6):583-95.

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes

Delgado M, Martínez C, Johnson MC, Gomariz RP, Ganea D.

J Neuroimmunol. 1996 Aug;68(1-2):27-38.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis

Delgado M, Garrido E, Martínez C, Leceta J, Gomariz RP.

Blood. 1996 Jun 15;87(12):5152-61. PDF

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes

Martínez C, Delgado M, Gomariz RP, Ganea D.

J Immunol. 1996 Jun 1;156(11):4128-36.

Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages

Delgado M, Pozo D, Martínez C, Garrido E, Leceta J, Calvo JR, Gomariz RP.

Regul Pept. 1996 Apr 23;62(2-3):161-6.

Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA

Johnson MC1, McCormack RJ, Delgado M, Martínez C, Ganea D.

J Neuroimmunol. 1996 Aug;68(1-2):109-19.

Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions

Delgado M, Garrido E, de la Fuente M, Gomariz RP.

Peptides. 1996;17(7):1097-105.

Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets

Delgado M, Martínez C, Leceta J, Garrido E, Gomariz RP.

Peptides. 1996;17(5):803-7.

VIP modulation of immune cell functions

De la Fuente M, Delgado M, Gomariz RP.

Adv Neuroimmunol. 1996;6(1):75-91. 

Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system

Leceta J, Martínez C, Delgado M, Garrido E, Gomariz RP.

Adv Neuroimmunol. 1996;6(1):29-36. 

Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP

Delgado M, De la Fuente M, Martínez C, Gomariz RP.

J Neuroimmunol. 1995 Nov;62(2):137-46.

Receptors for pituitary adenylate cyclase-activating peptide in human liver

Guijarro LG, Rodríguez-Henche N, García-López E, Noguerales F, Dapena MA, Juarranz MG, Prieto JC.

J Clin Endocrinol Metab. 1995 Aug;80(8):2451-7.